These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 20519939

  • 1. Expression of Hc fragment from Clostridium botulinum neurotoxin serotype B in Escherichia coli and its use as a good immunogen.
    Gao YL, Gao S, Kang L, Nie C, Wang JL.
    Hum Vaccin; 2010 Jun; 6(6):462-6. PubMed ID: 20519939
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Protection with a recombinant Hc of Clostridium Botulinum neurotoxin serotype A from Escherichia coli as an effective subunit vaccine.
    Yu YZ, Sun ZW, Li N, Wang S, Wang RL, Yu WY.
    Immunopharmacol Immunotoxicol; 2009 Jun; 31(2):261-6. PubMed ID: 18932057
    [Abstract] [Full Text] [Related]

  • 4. Protective potential of recombinant non-purified botulinum neurotoxin serotypes C and D.
    Moreira C, da Cunha CE, Moreira GM, Mendonça M, Salvarani FM, Moreira ÂN, Conceição FR.
    Anaerobe; 2016 Aug; 40():58-62. PubMed ID: 27236078
    [Abstract] [Full Text] [Related]

  • 5. Production and evaluation of a recombinant subunit vaccine against botulinum neurotoxin serotype B using a 293E expression system.
    Yu Y, Shi D, Liu S, Gong ZW, Wang S, Sun Z.
    Hum Vaccin Immunother; 2015 Aug; 11(2):468-73. PubMed ID: 25483668
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Expression, purification and characterization of the receptor-binding domain of botulinum neurotoxin serotype B as a vaccine candidate.
    Ben David A, Torgeman A, Barnea A, Zichel R.
    Protein Expr Purif; 2015 Jun; 110():122-9. PubMed ID: 25727047
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy of a potential trivalent vaccine based on Hc fragments of botulinum toxins A, B, and E produced in a cell-free expression system.
    Zichel R, Mimran A, Keren A, Barnea A, Steinberger-Levy I, Marcus D, Turgeman A, Reuveny S.
    Clin Vaccine Immunol; 2010 May; 17(5):784-92. PubMed ID: 20357058
    [Abstract] [Full Text] [Related]

  • 10. Development and evaluation of candidate subunit vaccine and novel antitoxin against botulinum neurotoxin serotype E.
    Shi DY, Liu FJ, Mao YY, Cui RT, Lu JS, Yu YZ, Dong XJ, Yang ZX, Sun ZW, Pang XB.
    Hum Vaccin Immunother; 2020 May; 16(1):100-108. PubMed ID: 31210561
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Purification, potency, and efficacy of the botulinum neurotoxin type A binding domain from Pichia pastoris as a recombinant vaccine candidate.
    Byrne MP, Smith TJ, Montgomery VA, Smith LA.
    Infect Immun; 1998 Oct; 66(10):4817-22. PubMed ID: 9746584
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Individual and bivalent vaccines against botulinum neurotoxin serotypes A and B using DNA-based Semliki Forest virus vectors.
    Yu Y, Yu J, Li N, Wang S, Yu W, Sun Z.
    Vaccine; 2009 Oct 19; 27(44):6148-53. PubMed ID: 19712769
    [Abstract] [Full Text] [Related]

  • 17. High level expression, purification and immunogenicity analysis of a protective recombinant protein against botulinum neurotoxin type E.
    Valipour E, Moosavi ML, Amani J, Nazarian S.
    World J Microbiol Biotechnol; 2014 Jun 19; 30(6):1861-7. PubMed ID: 24469548
    [Abstract] [Full Text] [Related]

  • 18. Recombinant Botulinum Neurotoxin Hc Subunit (BoNT Hc) and Catalytically Inactive Clostridium botulinum Holoproteins (ciBoNT HPs) as Vaccine Candidates for the Prevention of Botulism.
    Webb RP, Smith TJ, Smith LA, Wright PM, Guernieri RL, Brown JL, Skerry JC.
    Toxins (Basel); 2017 Sep 03; 9(9):. PubMed ID: 28869522
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.